Fresh Equities
Raises
Markets
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

ASX:PXS logo

ASX:PXS

Pharmaxis Ltd

Health Care / Pharmaceuticals

Current price

$0.085

0.002 (2.30%)

Last trade: Invalid date GMT

Market cap

$33.79m

Market closed

Investor Presentations

Principal Activity

Pharmaxis Limited (PXS) is a specialty pharmaceutical company involved in the research, development and commercialisation of therapeutic products for chronic respiratory disorders. PXS has two approved products: Bronchitol for cystic fibrosis and Aridol diagnosis of asthma; and four products in development: PXS-4728, LOX platform technology Orbital, ASM8. Headquartered in Sydney at its Frenchs Forest manufacturing facilities, Pharmaxis also has offices in Europe and the United States. Former Names Pharmaxis Limited PXS (11/11/2003)


Address

2/20 Rodborough Rd, Frenchs Forest NSW 2086, Australia

News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Rows per page:

5

6-10 of 10

Market Data

Day

3m

1yr

5yr

Current price

-

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Sector Peers

CompanyMarket Cap
Fresh Equities
App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.